发明名称 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
摘要 Disclosed are methods for producing fusion proteins with the heterodimeric cytokine, interleukin-12. In order to insure that the proper ratio of fused and non-fused subunits are obtained in the fusion protein, a specific stepwise approach to genetic engineering is used. This consists of first expressing the non-fused p40 IL-12 subunit in a production cell line, followed by or simultaneously expressing in the same cell, a second recombinant fusion protein consisting of the fused polypeptide linked by a peptide bond to the p35 subunit of IL-12. Molecules containing the p35 fusion protein cannot be secreted from the transfected mammalian cell without first complexing in a one to one ratio with the p40 subunit, thus ensuring the production of active heterodimeric fusion proteins.
申请公布号 US7879319(B2) 申请公布日期 2011.02.01
申请号 US20090498491 申请日期 2009.07.07
申请人 MERK PATENT GMBH 发明人 GILLIES STEPHEN D.;LO KIN-MING;LAN YAN
分类号 A61K38/19;C12N15/09;A61K38/00;A61K38/20;A61K47/48;A61P37/04;C07K14/54;C07K16/30;C07K19/00;C12P21/00 主分类号 A61K38/19
代理机构 代理人
主权项
地址